Insulinoma: Diagnosis, Outlook, and Modern Treatment Approaches

Insulinoma causes excess insulin release, leading to recurrent hypoglycemia. Typical symptoms include sweating, shakiness, confusion, hunger, and fainting that improve after eating.
Key Takeaways
- Insulinoma causes excess insulin release, leading to recurrent hypoglycemia.
- Typical symptoms include sweating, shakiness, confusion, hunger, and fainting that improve after eating.
- Diagnosis usually combines documented low blood sugar, blood tests taken during an episode, and imaging to find the tumor.
- Surgery is the main treatment for many people and can often be curative.
- Medicines, nutrition strategies, and targeted procedures may help when surgery is not suitable or the tumor has spread.
- Prompt medical review is important for unexplained hypoglycemia, seizures, blackouts, or recurrent confusion.
Insulinoma is a rare pancreatic neuroendocrine tumor that makes too much insulin and can cause repeated episodes of low blood sugar. Most insulinomas are small and noncancerous, and modern diagnosis and treatment often lead to very good outcomes.
Overview
Insulinoma is a tumor that starts in the insulin-producing cells of the pancreas. It releases insulin even when the body does not need it, which can drive blood sugar too low. This causes episodes of hypoglycemia that may come and go, sometimes for months before the cause is recognized.
Most insulinomas are small, solitary, and noncancerous. They belong to a group called pancreatic neuroendocrine tumors, which behave differently from the more common types of pancreatic cancer. Because the condition is uncommon and symptoms can mimic anxiety, fainting disorders, or neurological problems, diagnosis may take time.
The outlook is often favorable when the tumor is found and treated appropriately. A careful approach usually includes confirming that symptoms are truly due to low blood sugar, identifying the source of excess insulin, and then choosing treatment based on the tumor’s size, location, and whether it has spread.
Symptoms and how insulinoma feels

Symptoms of insulinoma are caused by low blood sugar rather than by the tumor itself. Episodes may happen after fasting, overnight, after exercise, or sometimes at unpredictable times during the day. Many people notice that symptoms improve fairly quickly after eating or drinking something containing sugar.
Common symptoms can include shakiness, sweating, a fast heartbeat, anxiety, intense hunger, weakness, headache, blurred vision, and trouble concentrating. When blood sugar drops further, a person may become confused, behave unusually, slur speech, faint, or have a seizure. In some cases, repeated low blood sugar is first mistaken for panic attacks, epilepsy, or another neurological condition.
Because episodes often improve with food, some people gain weight over time from frequent snacking to prevent symptoms. Keeping a record of when symptoms occur, what the person was doing, and whether they improved after eating can be helpful for the doctor.
- Early warning symptoms: tremor, sweating, palpitations, hunger, tingling
- Low-brain-glucose symptoms: confusion, irritability, poor focus, blurred vision, unusual behavior
- More severe symptoms: collapse, seizure, loss of consciousness
Causes and risk factors
Insulinoma develops when a group of pancreatic cells grows abnormally and continues to secrete insulin. In most people, the exact reason this happens is not known. The condition is usually not caused by lifestyle choices, and it is not the same as the much more common problem of diabetes-related low blood sugar from insulin or other medicines.
Most insulinomas occur as a single tumor. A smaller number are linked to an inherited syndrome called multiple endocrine neoplasia type 1, or MEN1, in which tumors can occur in more than one hormone-producing gland. Doctors may think about inherited causes when insulinoma appears at a younger age, when there are multiple pancreatic tumors, or when there is a family history of endocrine tumors.
It is also important to distinguish insulinoma from other causes of hypoglycemia, such as accidental or deliberate use of insulin, certain diabetes tablets, severe liver disease, adrenal problems, critical illness, alcohol-related hypoglycemia, or other rare endocrine disorders. This is why diagnosis focuses not only on finding a tumor, but on proving that excess insulin is responsible for the low blood sugar.
How insulinoma is diagnosed
Diagnosis usually starts with confirming Whipple’s triad: symptoms of low blood sugar, a documented low glucose level during symptoms, and relief after the blood sugar is corrected. This helps the medical team determine that the episodes are truly hypoglycemia and not another condition.
Blood tests taken during an episode are central to diagnosis. Doctors typically measure glucose together with insulin, C-peptide, and related markers to see whether the body is making too much insulin at the wrong time. In some cases, a supervised fasting test in hospital is used to safely trigger and document an episode while the team monitors the patient closely.
Once biochemistry suggests insulinoma, imaging is used to locate the tumor. This may include MRI, CT scanning, or specialized endoscopic ultrasound. If the tumor is difficult to find, additional functional imaging or selective vascular testing may be considered in expert centers. Because insulinoma belongs to the broader family of neuroendocrine tumors, diagnosis may involve specialists in endocrinology, radiology, gastroenterology, surgery, and pathology.
Some patients also have routine blood tests to check overall health and to look for clues suggesting MEN1 or other endocrine conditions. When family history raises concern, genetic counseling and testing may be discussed.
Modern treatment approaches
Treatment is tailored to the person and the tumor. For many patients, surgery is the main treatment and offers the best chance of cure. The operation depends on where the tumor sits in the pancreas and whether there is one lesion or several. Small, well-defined tumors may sometimes be removed by enucleation, while others require a larger pancreatic operation.
Before treatment, doctors often focus on preventing further hypoglycemia. This may involve eating regular meals and snacks, avoiding long periods without food, and using medicines that reduce insulin release or raise blood sugar. These measures can also be important for people who need time for further testing or who are not immediate candidates for surgery.
If the disease is more complex, such as when there are multiple tumors, recurrence, or spread to other organs, a wider range of therapies may be used. These can include liver-directed procedures, targeted systemic treatment, or peptide receptor-based approaches depending on tumor features. In selected cases, pancreatic surgery and related pancreatic tumor treatment and specialist neuroendocrine tumor therapies may be part of the care plan, even though insulinoma often behaves differently from more aggressive pancreatic cancers such as pancreatic cancer.
The best plan is usually made by a multidisciplinary team. This helps balance tumor control with protection of pancreatic function and day-to-day quality of life.
Outlook and living with insulinoma
The outlook for insulinoma is often very good, especially when the tumor is localized and can be removed completely. Many people experience full resolution of hypoglycemia after successful treatment. Follow-up still matters, because doctors need to confirm that symptoms have stopped and to monitor for recurrence in selected patients.
If the tumor is malignant or has spread, outlook varies more widely and depends on factors such as tumor grade, growth rate, location of metastases, and response to treatment. Even in these situations, modern therapies can often help control hypoglycemia and manage the disease for long periods. The goals are to keep blood sugar stable, reduce symptoms, and treat the tumor in a way that fits the patient’s overall health.
Living with recurrent hypoglycemia can affect work, driving, exercise, and emotional well-being. Until the condition is controlled, patients may be advised to take precautions, such as carrying a rapid source of glucose, informing close contacts about symptoms, and discussing driving safety with their clinician. For international patients who need coordinated evaluation, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat insulinoma as part of comprehensive endocrine and pancreatic care.
Prevention and self-care
There is no proven way to prevent insulinoma itself. However, self-care can lower the risk of severe low blood sugar while the person is being assessed or treated. The aim is not to replace medical care, but to reduce sudden drops in glucose and improve safety.
Helpful measures may include eating regularly, avoiding long fasts, carrying glucose tablets or another quick sugar source, and asking a clinician which symptoms should prompt urgent action. Family members or coworkers can be told how low blood sugar may look and what to do while waiting for medical help.
- Do not skip meals if fasting tends to trigger symptoms.
- Keep a symptom diary, including timing, activity, and response to food.
- Wear medical identification if episodes are severe or unpredictable.
- Discuss driving, swimming, heights, and heavy machinery if fainting or confusion has occurred.
People should avoid self-diagnosing recurrent hypoglycemia. Blood sugar symptoms can have different causes, and the safest plan depends on proper medical evaluation.
When to seek medical care
Medical care should be sought promptly for repeated episodes of sweating, shakiness, confusion, or fainting that improve after eating, especially if they happen during fasting or overnight. A doctor should also review unexplained seizures, blackouts, unusual behavior, or recurrent low glucose readings on a home device.
Urgent care is important if a person becomes hard to wake, loses consciousness, has a seizure, or cannot swallow safely during a suspected low blood sugar episode. In that situation, emergency services should be contacted. Early evaluation can help identify the cause and prevent future episodes.
Even when symptoms seem mild, repeated hypoglycemia deserves assessment by a qualified clinician. Timely testing can distinguish insulinoma from other causes and guide treatment before episodes become more disruptive or dangerous.
Frequently asked questions
Is insulinoma usually cancer?
No. Most insulinomas are benign, meaning they do not behave like cancer or spread to distant organs. A smaller number are malignant, so doctors still assess the tumor carefully and arrange follow-up based on the findings.
What is the first sign of insulinoma?
For many people, the earliest clues are episodes of low blood sugar such as sweating, tremor, hunger, palpitations, or difficulty concentrating. Symptoms often improve after eating, which can be an important clue for diagnosis.
How do doctors confirm insulinoma?
Doctors confirm insulinoma by showing that symptoms happen with low blood sugar and that insulin levels are inappropriately high at that time. Imaging tests are then used to locate the tumor and plan treatment.
Can insulinoma be cured?
It often can be, especially when there is a single localized tumor that can be removed surgically. If cure is not possible, treatment can still help control low blood sugar and manage the tumor over time.
Is insulinoma the same as diabetes?
No. Insulinoma causes excess insulin and low blood sugar, while diabetes is usually associated with problems making or using insulin and often leads to high blood sugar. The two conditions are different, although some symptoms can overlap with medication-related hypoglycemia in people with diabetes.
What should someone do during a suspected low blood sugar episode?
If the person is awake and able to swallow, they should take a quick source of sugar and seek medical advice, especially if episodes are recurrent. If the person is confused, having a seizure, unconscious, or unable to swallow safely, emergency help is needed immediately.
References
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Cancer Institute
- National Organization for Rare Disorders
- European Society for Medical Oncology
- Endocrine Society
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Oncology care in Turkey — second opinion and treatment plan
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.









